Literature DB >> 195701

Malignant parotid tumors: natural history and treatment.

S Rafla.   

Abstract

Sixty-seven cases of histologically proven malignant parotid tumors are presented. Forty percent of the tumors were differentiated adenocarcinoma, while malignant mixed tumors (or pleomorphic adenocarcinomas) formed 18%. The remaining types of malignant salivary tumors are also represented in the series. The natural history and spread of these tumors are studied in detail, with lymph-node metastasis occurring in 25% of the cases and distant metastasis in 20%. Malignant tumors involve largely the retromandibular portion of the parotid gland in over 40% of the cases and the preauricular portion in about one-fifth of the cases. Both regions are affected in a further fifth of the cases. A combination of surgery and radiotherapy was the method employed for curative therapy, with radiotherapy alone reserved mainly for palliation. While the overall five-year survival was 42%, late recurrences constitute a serious problem with eventual demise of about half of these patients. Various factors affecting the prognosis, including histological type of tumor, method of treatment and response to radiotherapy are discussed.

Entities:  

Mesh:

Year:  1977        PMID: 195701     DOI: 10.1002/1097-0142(197707)40:1<136::aid-cncr2820400123>3.0.co;2-a

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Malignant salivary gland tumors: role of radiation therapy.

Authors:  E K Reddy; C M Mansfield; G V Hartman; E Rouby
Journal:  J Natl Med Assoc       Date:  1979-10       Impact factor: 1.798

Review 2.  Cancer of the parotid gland: role of 7th nerve preservation.

Authors:  Jeffrey D Spiro; Ronald H Spiro
Journal:  World J Surg       Date:  2003-07       Impact factor: 3.352

3.  Radiotherapy for parotid cancer.

Authors:  L M Toonkel; S Guha; P Foster; V Dembrow
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

4.  Risk of nodal metastases from malignant salivary gland tumors related to tumor size and grade of malignancy.

Authors:  S Rodríguez-Cuevas; S Labastida; L Baena; F Gallegos
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Effect of clinical symptoms on the indication for selective neck dissection for N0 carcinomas of the parotid gland.

Authors:  Takashi Maruo; Yasushi Fujimoto; Kenji Yoshida; Mariko Hiramatsu; Atsushi Suzuki; Naoki Nishio; Mariko Shimono; Tsutomu Nakashima
Journal:  Oncol Lett       Date:  2014-05-12       Impact factor: 2.967

6.  The efficacy of iodine-125 permanent brachytherapy versus intensity-modulated radiation for inoperable salivary gland malignancies: study protocol of a randomised controlled trial.

Authors:  Shu-Ming Liu; Hai-Bo Wang; Yan Sun; Yan Shi; Jie Zhang; Ming-Wei Huang; Lei Zheng; Xiao-Ming Lv; Bao-Min Zheng; Kathleen H Reilly; Xiao-Yan Yan; Ping Ji; Yang-Feng Wu; Jian-Guo Zhang
Journal:  BMC Cancer       Date:  2016-03-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.